[Avastin a treatment of diabetic macular edema]

Abstract

Macular edema is the first cause of visual impairment in diabetic patient. This paper is a retrospective evaluation of a group of patients with diabetic retinopathy and macular edema, treated with intravitreal Avastin (Bevacizumab) injection. The patients have been monitored mainly by assessing the evolution of visual acuity and macular thickness (OCT), after treatment, and the results have been compared with preexisting literature data.